Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 7, 2016
A PET/MRI study towards finding the optimal [<sup>18</sup>F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer
Mattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Gigascience
|
May 14, 2025
Spatial integration of multi-omics data from serial sections using the novel Multi-Omics Imaging Integration Toolset
Maximilian Wess, Maria K Andersen, Elise Midtbust, et al.
Investigative Radiology
|
September 27, 2012
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology
Kirsten M Selnæs, Arend Heerschap, Line R Jensen, et al.
Plos One
|
April 30, 2013
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness
Guro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2017
Combined <sup>18</sup>F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
Mattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
British Journal of Cancer
|
December 4, 2015
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Guro F Giskeødegård, Ailin Falkmo Hansen, Helena Bertilsson, et al.
Biopreservation and Biobanking
|
April 10, 2025
Biobanking after Radical Prostatectomy: Comparison of Slice and Punch Protocols
Anders Blilie, Guro F Giskeødegård, Åsmund Nybøen, et al.
NMR in Biomedicine
|
January 15, 2022
Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy
Ailin Falkmo Hansen, Therese Stork Høiem, Kirsten Margrete Selnaes, et al.
Oncotarget
|
June 9, 2016
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
Ailin Falkmo Hansen, Elise Sandsmark, Morten Beck Rye, et al.
Oncotarget
|
December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressiveness
Elise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
European Journal of Nuclear Medicine and Molecular Imaging
|
November 7, 2016
A PET/MRI study towards finding the optimal [<sup>18</sup>F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer
Mattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
Gigascience
|
May 14, 2025
Spatial integration of multi-omics data from serial sections using the novel Multi-Omics Imaging Integration Toolset
Maximilian Wess, Maria K Andersen, Elise Midtbust, et al.
Investigative Radiology
|
September 27, 2012
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology
Kirsten M Selnæs, Arend Heerschap, Line R Jensen, et al.
Plos One
|
April 30, 2013
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness
Guro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 8, 2017
Combined <sup>18</sup>F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer
Mattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, et al.
British Journal of Cancer
|
December 4, 2015
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
Guro F Giskeødegård, Ailin Falkmo Hansen, Helena Bertilsson, et al.
Biopreservation and Biobanking
|
April 10, 2025
Biobanking after Radical Prostatectomy: Comparison of Slice and Punch Protocols
Anders Blilie, Guro F Giskeødegård, Åsmund Nybøen, et al.
NMR in Biomedicine
|
January 15, 2022
Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy
Ailin Falkmo Hansen, Therese Stork Høiem, Kirsten Margrete Selnaes, et al.
Oncotarget
|
June 9, 2016
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
Ailin Falkmo Hansen, Elise Sandsmark, Morten Beck Rye, et al.
Oncotarget
|
December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressiveness
Elise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Page
of 6